Daiichi Sankyo US is hosting a session at RISW 2026 focused on precision oncology applications including digital pathology and digital surrogate endpoints.
Published
Signal category
Presence & Recognition
Quote
“Looking forward to hosting this session at RISW 2026, focused on two emerging applications in precision oncology”
— Sutan Wu|Daiichi Sankyo US team
Company
Daiichi Sankyo US
We create life-changing solutions for patients.
- Industry
- Pharmaceutical Manufacturing
- Location
- Basking Ridge, US
- Company size
- 4,407 employees
At Daiichi Sankyo, we create essential medicine for longer, better lives. By uniting cutting edge science and technology with a genuine interest in people, we develop high quality, life changing solutions for the patients of today and tomorrow with great care and unwavering dedication. With more than 125+ years of experience, Daiichi Sankyo leverages its world-class science and technology to create new modalities and innovative medicines for people with cancer, cardiovascular, and other diseases with high unmet medical need. For more information, please visit www.daiichisankyo.us. See our community guidelines here: https://bit.ly/4fLkZS8